KORU Medical Systems Incの最新の1株当たり利益は$-0.02で、$-0.02の予想を殴打しない。
KORU Medical Systems Inc KRMDの前四半期の収益はどうでしたか?
KORU Medical Systems Incの前四半期の収益は$-0.02です。
KORU Medical Systems Incの収益見積もりはいくらですか?
7人のウォール街のアナリストによると、KORU Medical Systems Incの収益見積もりは$12.28Mから$11.21Mの範囲です。
KORU Medical Systems Incの収益品質スコアはどれくらいですか?
KORU Medical Systems Incの収益品質スコアはA-/58.526062です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
KORU Medical Systems Incはいつ収益を報告しますか?
KORU Medical Systems Incの次の収益報告は2026-08-04に予定されています
KORU Medical Systems Incの予想収益はいくらですか?
ウォール街のアナリストによると、KORU Medical Systems Incの予想収益は$11.5Mです。
KORU Medical Systems Incは収益予想を上回りましたか?
KORU Medical Systems Incの最近の収益は$11.76Mで、予想をビート。
主要データ
前終値
$3.98
始値
$3.92
当日レンジ
$3.87 - $4
52週レンジ
$2.62 - $6.6
取引高
147.0K
平均取引高
173.4K
配当利回り
--
1株当たり利益(TTM)
-0.05
時価総額
$185.2M
KRMDとは何ですか?
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.